Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 19
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02955446 | Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies | ||
| NCT06843967 | A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma | ||
| NCT05580770 | Mirdametinib + BGB-3245 in Advanced Solid Tumors | ||
| NCT07176689 | Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) | ||
| NCT06159166 | Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). | ||
| NCT07170644 | A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) | ||
| NCT04195399 | A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery | ||
| NCT03785964 | Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) | ||
| NCT05879146 | Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study | ||
| NCT05028166 | Individual Patient Compassionate Use of Mirdametinib | ||
| NCT06997276 | Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib | ||
| NCT05949099 | Study of Cryoablation and Nirogacestat for Desmoid Tumor | ||
| NCT05041036 | Individual Patient Compassionate Use of Nirogacestat | ||
| NCT05348356 | Nirogacestat in Ovarian Granulosa Cell Tumors | ||
| NCT06251310 | SW-682 in Advanced Solid Tumors | ||
| NCT07171619 | Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat | ||
| NCT04923126 | SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma | ||
| NCT03905148 | Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors | ||
| NCT03962543 | MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas |
